Skeletal Editing: Interconversion of Arenes and Heteroarenes
Helvetica Chimica Acta · 2023-03 · 106 (3)
DOI: 10.1002/hlca.202200182 ↗Kurz gefasst
Fachartikel in der Zeitschrift Helvetica Chimica Acta, online erschienen am 03.02.2023. Verfasst von Ben W. Joynson und 1 weiteren Autor:innen. Die Arbeit wurde bisher 271-mal zitiert (Crossref) und nennt 117 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Eli Lilly and Company, UK Research and Innovation.
Abstract (Originalsprache)
Skeletal editing involves making specific point‐changes to the core of a molecule through the selective insertion, deletion or exchange of atoms. It thus represents a potentially powerful strategy for the step‐economic modification of complex substrates and is a perfect complement to methods such as C−H functionalization that target the molecular periphery. Given their ubiquity in biologically active compounds, the ability to perform skeletal editing on – and therefore interconvert between – aromatic heterocycles is especially valuable. This review summarizes both recent and key historical examples of skeletal editing as applied to interconversion of aromatic rings; we anticipate that it will serve to highlight not only the innovative and enabling nature of current skeletal editing methods, but also the tremendous opportunities that still exist in the field.
Förderung
- Eli Lilly and Company
- UK Research and Innovation
Zitieren
APA
Joynson, B. W., & Ball, L. T. (2023). Skeletal Editing: Interconversion of Arenes and Heteroarenes. Helvetica Chimica Acta, 106(3). https://doi.org/10.1002/hlca.202200182
Vancouver
Joynson BW, Ball LT. Skeletal Editing: Interconversion of Arenes and Heteroarenes. Helvetica Chimica Acta. 2023;106(3). doi:10.1002/hlca.202200182
BibTeX
@article{Joynson2023,
author = {Joynson, Ben W. and Ball, Liam T.},
title = {Skeletal Editing: Interconversion of Arenes and Heteroarenes},
journal = {Helvetica Chimica Acta},
year = {2023},
volume = {106},
number = {3},
doi = {10.1002/hlca.202200182}
}
EUVIMED